{
  "id": 2886,
  "text": "Adjuvant chemotherapy in \"high risk\" patients after Wertheim hysterectomy--10-year survivals.Ann Acad Med Singapore 27, 622-626 (1998).743.Argenta, P.A., et al.Radiation therapy with concomitant and adjuvant cisplatin and paclitaxel in high-risk cervical cancer: long-term follow-up.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Adjuvant chemotherapy in \"high risk\" patients after Wertheim hysterectomy--10-year survivals.Ann Acad Med Singapore 27, 622-626 (1998).743.Argenta, P.A., et al.Radiation therapy with concomitant and adjuvant cisplatin and paclitaxel in high-risk cervical cancer: long-term follow-up.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在临床治疗中，高风险宫颈癌患者在接受Wertheim子宫切除术后可能需要进一步化疗或放疗的因素主要包括：肿瘤的病理特征、手术后的病理阶段、淋巴结的转移情况、肿瘤切缘是否干净（即是否有残留癌细胞），以及其他高风险病理特征如肿瘤的分化程度、脉管浸润等。此外，患者总体健康状况和个体对治疗的反应也可能影响后续治疗的选择。结合全面的病理评估及患者的总体健康状况，临床医生将制定个体化的治疗方案，以提供最有效的治疗。",
  "query": "在临床治疗中，哪些因素会导致高风险宫颈癌患者在接受Wertheim子宫切除术后需要进一步的化疗或放疗？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在临床治疗中，哪些因素会导致高风险宫颈癌患者在接受Wertheim子宫切除术后需要进一步的化疗或放疗？\n\n<reference text>: Adjuvant chemotherapy in \"high risk\" patients after Wertheim hysterectomy--10-year survivals.Ann Acad Med Singapore 27, 622-626 (1998).743.Argenta, P.A., et al.Radiation therapy with concomitant and adjuvant cisplatin and paclitaxel in high-risk cervical cancer: long-term follow-up.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在临床治疗中，高风险宫颈癌患者在接受Wertheim子宫切除术后可能需要进一步化疗或放疗的因素主要包括：肿瘤的病理特征、手术后的病理阶段、淋巴结的转移情况、肿瘤切缘是否干净（即是否有残留癌细胞），以及其他高风险病理特征如肿瘤的分化程度、脉管浸润等。此外，患者总体健康状况和个体对治疗的反应也可能影响后续治疗的选择。结合全面的病理评估及患者的总体健康状况，临床医生将制定个体化的治疗方案，以提供最有效的治疗。"
}